NCT03952520Completed
Scaling up an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam: an Implementation Trial
Scaling up HIV Prevention Trials Network (HPTN) 074: a Cluster Randomized Implementation Trial of an Evidence-based Intervention for Antiretroviral Therapy for PWID in Vietnam
Source: ClinicalTrials.gov · Last updated 11 May 2025
Brief summary (registry, in English)
The purpose of this study is to compare two implementation approaches \[Standard Approach (SA) vs. Tailored Approach (TA)\] for scaling-up the evidence-based systems navigation and psychosocial counseling integrated intervention (SNaP) in HIV test sites in Vietnam.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1000 (actual)
- First submitted
- 14 May 2019
- Start date
- 10 Jun 2020
- Primary completion date
- 31 Jul 2023
- Lead sponsor
- University of North Carolina, Chapel Hill
- Diseases
- HIV
- NCT number
- NCT03952520
What you commit to
- Study type: Interventional
- Participants enrolled: 1000
- From 10 Jun 2020 to the primary completion date, 31 Jul 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Residence outside of the catchment area of local antiretroviral therapy (ART) and medication-assisted treatment (MAT, e.g. methadone) clinics
- Currently on ART at time of study enrollment (self-reported)
Other
- PWID participants:
- Planning to move out of the catchment area within the next 24 months.
Who the study is looking for
- PWID participants:
- HIV infection:
- Newly diagnosed HIV infection, based on confirmatory test, and not currently on ART at the time of study enrollment; or
- If previously diagnosed with HIV infection, then must not currently be on ART at the time of study enrollment (self-reported)
- Age 18 years or older
- Injection drug use within the past 6 months (self-reported at time of screening)
- Willing to provide informed consent for the study
- Test site director boards and staff:
- All test site director boards and staff, including the navigators and counselors, at the selected HIV test sites
- Willing to provide informed consent for the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hanoi Medical University Coordinator of this site? Confirm its status | Hanoi | Vietnam | Unknown status |
Related publications
- Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trial.Lancet Glob Health · 2025 · PMID 41240949
This page is information, not medical advice. Discuss any trial with your doctor.